Flufenamic acid in rheumatoid arthritis. The second six months of treatment.
D000410:Alanine Transaminase / Q000097:blood; D000429:Alcohol Oxidoreductases / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000201:enzymology; D001219:Aspartate Aminotransferases / Q000097:blood; D002908:Chronic Disease; D005439:Flufenamic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D005461:Fluorine / Q000627:therapeutic use; D005634:Fructose-Bisphosphate Aldolase / Q000097:blood; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D013997:Time Factors; D062367:ortho-Aminobenzoates / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D062367:ortho-Aminobenzoates; D005461:Fluorine; D005439:Flufenamic Acid; D000429:Alcohol Oxidoreductases; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D005634:Fructose-Bisphosphate Aldolase